OPSOCLON-MYOCLON SYNDROME ASSOCIATED WITH INFECTION
DOI:
https://doi.org/10.5281/zenodo.23818339Keywords:
Opsoclonus-Myoclonus Syndrome, HIV Infections, Oligoclonal BandsAbstract
Opsoclonus-myoclonus syndrome (OMS) is a rare neurological condition characterized by opsoclonus, myoclonus, and ataxia; its presentation in adults necessitates an extensive search for the underlying etiology, including paraneoplastic, infectious, and autoimmune causes. We report the case of a 44-year-old male with HIV infection on antiretroviral therapy who presented with a subacute onset of headache, gait instability, and multidirectional eye movements. Imaging revealed longitudinally extensive myelitis (T5–T9) predominantly affecting the posterior columns, while cerebrospinal fluid analysis showed mononuclear pleocytosis, elevated protein levels, and intrathecal IgG synthesis evidenced by oligoclonal bands. Although the CSF VDRL test was negative, a history of syphilis, a reactive serum VDRL, compatible neurological symptoms, and intrathecal inflammation supported a suspicion of probable neurosyphilis. Relevant differential diagnoses in HIV patients were discussed, including autoimmune demyelinating disorders such as neuromyelitis optica spectrum disorder. The patient was treated with penicillin G and methylprednisolone, showing partial clinical improvement. This case highlights the utility of cerebrospinal fluid analysis in determining the etiology of OMS in HIV patients, as well as the need to integrate epidemiological history, imaging findings, and therapeutic response when facing complex diagnostic scenarios.
Downloads
References
1. Martinez Popple M, Severino M, Preiti D, Conte M, Pistorio A, Zoia A, et al. Pediatric opsoclonus-myoclonus-ataxia syndrome can lead to long-term neurological, neuropsychological, and cognitive sequelae associated with cerebellar atrophy. Cerebellum. 2025;24(4):97. doi:10.1007/s12311-025-01846-7.
2. Oh SY, Kim JS, Dieterich M. Update on opsoclonus-myoclonus syndrome in adults. J Neurol. 2019;266(6):1541-8. doi:10.1007/s00415-018-9138-7.
3. Nožić Škerjanec T, Berlot R. Adult-onset opsoclonus-myoclonus-ataxia syndrome accompanying an infection with tick-borne encephalitis virus: a case report. Acta Neurol Belg. 2025;125(5):1437-9. doi:10.1007/s13760-025-02820-0.
4. He F, Kessi M, Zhang C, Peng J, Yin F, Yang L. The utilization of the multimodal immunotherapy for the opsoclonus-myoclonus syndrome can reduce relapses and permanent neurological sequelae. Ital J Pediatr. 2025;51(1):33. doi:10.1186/s13052-025-01875-
5. Dalmau J, Rosenfeld MR. Opsoclonus-myoclonus-ataxia syndrome. En: UpToDate [Internet]. Waltham (MA): UpToDate; 2025 nov 6 [citado 2026 ago 14]. Disponible en: https://www.uptodate.com/contents/opsoclonus-myoclonus-ataxia-syndrome
6. Jiménez Legido M, Cantarín Extremera V, Fournier del Castillo MC, Melero Llorente J, González Gutiérrez-Solana L. Síndrome opsoclonus mioclonus. Experiencia en los últimos 12 años en un hospital terciario. An Pediatr (Barc). 2020;93(5):339-42. doi:10.1016/j.anpedi.2019.12.007.
7. Yıldırım M, Öncel İ, Bektaş Ö, Tanalı G, Anlar B. Clinical features and outcomes of opsoclonus myoclonus ataxia syndrome. Eur J Paediatr Neurol. 2022;41:19-26. doi:10.1016/j.ejpn.2022.09.002.
8. Ropper AH, Samuels MA, Klein JP, Prasad S. Neoplasias intracraneales y trastornos paraneoplásicos. En: Adams y Victor. Principios de neurología. 12a ed. New York: McGraw-Hill Education; 2023 [citado 2026 abr 26]. Disponible en: https://accessmedicina.mhmedical.com/content.aspx?bookid=3353§ionid=281620897
9. Armangué T, Sabater L, Torres-Vega E, Martínez-Hernández E, Ariño H, Petit-Pedrol M, et al. Clinical and immunological features of opsoclonus-myoclonus syndrome in the era of neuronal cell surface antibodies. JAMA Neurol. 2016;73(4):417-24. doi:10.1001/jamaneurol.2015.4607.
10. Jarius S, Aktas O, Ayzenberg I, et al. Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis. J Neurol. 2023;270:3341-3368. doi:10.1007/s00415-023-11634-0.
11. Rossor T, Yeh EA, Khakoo Y, Angelini P, Hemingway C, Irani SR, et al.; OMS Study Group. Diagnosis and management of opsoclonus-myoclonus-ataxia syndrome in children: an international perspective. Neurol Neuroimmunol Neuroinflamm. 2022;9(3):e1153. doi:10.1212/NXI.0000000000001153.
12. Cabaraux P, Poncelet A, Honnorat J, Demeester R, Cherifi S, Manto M. CSF HIV RNA escape in opsoclonus-myoclonus-ataxia syndrome: case report and review of the literature. Front Neurol. 2020;11:585527. doi:10.3389/fneur.2020.585527. Disponible en: https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2020.585527
13. Mathew T, Avati A, D'Souza D, Therambil M, Baptist AA, Shaji A, et al. HIV infection associated neuromyelitis optica spectrum disorder: clinical features, imaging findings, management and outcomes. Mult Scler Relat Disord. 2019;27:289-93. doi:10.1016/j.msard.2018.11.014.
14. Flores Rivera JJ, Arrambide García G, Mireles Ramírez M, Macías Islas MA, Lozano Zárate JA, Molina Carrión LE, et al. Enfermedades desmielinizantes. En: Neurología elemental. Barcelona: Elsevier; 2024. p. 315-336.e11.
15. Glisson CC. Neuromyelitis optica spectrum disorder (NMOSD): clinical features and diagnosis. En: UpToDate [Internet]. Waltham (MA): UpToDate; 2026 jun 29 [citado 2026 ago 14]. Disponible en: https://www.uptodate.com/contents/neuromyelitis-optica-spectrum-disorder-nmosd-clinical-features-and-diagnosis
16. Tohge R, Shinoto Y, Takahashi M. Longitudinally extensive transverse myelitis and optic neuropathy associated with syphilitic meningomyelitis and human immunodeficiency virus infection: a case report and review of the literature. Intern Med. 2017;56(15):2067-72. doi:10.2169/internalmedicine.56.8236.
17. Yuan JL, Wang WX, Hu WL. Clinical features of syphilitic myelitis with longitudinally extensive myelopathy on spinal magnetic resonance imaging. World J Clin Cases. 2019;7(11):1282-90. doi:10.12998/wjcc.v7.i11.1282.
18. Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV. Syphilis: adult and adolescent opportunistic infections guidelines [Internet]. Bethesda (MD): National Institutes of Health; 2026 may 27 [citado 2026 jun 1]. Disponible en: https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/syphilis
19. Centers for Disease Control and Prevention. Syphilis [Internet]. Atlanta (GA): Centers for Disease Control and Prevention; 2024 oct 3 [citado 2026 ago 12]. Disponible en: https://www.cdc.gov/std/treatment-guidelines/syphilis.htm
20. Marra CM. Neurosyphilis. En: UpToDate [Internet]. Waltham (MA): UpToDate; 2024 may 30 [citado 2026 ago 14]. Disponible en: https://www.uptodate.com/contents/neurosyphilis
21. Shah BB, Lang AE. A case of neurosyphilis presenting with myoclonus, cerebellar ataxia, and speech disturbance. Mov Disord. 2012;27(6):794. doi:10.1002/mds.24952.
22. Huang X, Ying S, Luo L, Li L, Li D, Xie Y. Intrathecal immunoglobin synthesis and its role in patients with neurosyphilis. Front Public Health. 2022;10:1008595. doi:10.3389/fpubh.2022.1008595.
23. De Almeida SM, Rotta I, Tang B, Vaida F, Letendre S, Ellis RJ, et al. IgG intrathecal synthesis in HIV-associated neurocognitive disorder (HAND) according to the HIV-1 subtypes and pattern of HIV RNA in CNS and plasma compartments. J Neuroimmunol. 2021;356:577542. doi:10.1016/j.jneuroim.2021.577542.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Macarena Muñoz Fuentealba, Silvana Villalobos Pérez, Sebastián Arriagada Leiva (Autor/a)

This work is licensed under a Creative Commons Attribution 4.0 International License.









